ARSI Canada Inc

Overview

ARSI Canada Inc is a premier North American Contract Research Organization (CRO) with over 50 years of cumulative experience in pharmaceutical research, drug discovery, and development. The organization serves the pharmaceutical, biotechnology, medical device, diagnostics, agrochemicals, and academic research sectors.

Core Services

Custom Synthesis & Scale-Up

• Custom synthesis of complex small molecules, APIs, and intermediates from milligram to kilogram scales
• Pre-clinical and pilot-scale manufacturing with process development and route optimization
• Synthesis of reference standards, impurity standards, and specialty reagents (including peptides and radiopharmaceuticals)
• Full analytical results and Certificate of Analysis (CoA) for all compounds

Analytical & Method Development

• Analytical method development and validation using chromatography and spectroscopy
• Structure elucidation via NMR, MS, and IR
• Forced degradation studies aligned with ICH guidelines
• Quality control and analytical verification at each scale-up phase

Drug Development Support

• Route development and lead optimization
• Process development and engineering with Design of Experiments (DoE) approach
• Technology transfer and process validation
• Regulatory guidance aligned with GMP standards and ICH guidelines

Manufacturing Capabilities

• R&D facility in Mississauga for non-GMP synthesis (mg to kg scale)
• GMP bulk manufacturing facility in Bangladesh with six 3000L reactors, multiple centrifuge machines, over 250 kg fluid bed dryers, and 250 MT annual capacity for GMP APIs and non-GMP intermediates
• 2000+ in-stock catalogue compounds for accelerated research

Operational Metrics

• 50+ professional staff and collaborators
• 99% client satisfaction rate
• 97% on-time project delivery
• 430+ tests completed
• Emphasis on quality, speed, flexibility, and data-driven decision-making